Brief: Abliva Gets New U.S. Patent For Therapeutic Compound NV354

Abliva AB

09/02/2023 07:36

Feb 9 (Reuters) - Abliva AB  ABLI.ST :
    * ANNOUNCES ISSUANCE OF A NEW U.S. PATENT FOR THERAPEUTIC
COMPOUND
NV354

Source text for Eikon:  ID:nMFN8HgFGb 
Further company coverage:  ABLI.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))